Annual Net Income
-$30.04 M
-$1.71 M-6.05%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual net profit is -$30.04 million, with the most recent change of -$1.71 million (-6.05%) on December 31, 2023.
- During the last 3 years, RGLS annual net income has fallen by -$14.31 million (-90.95%).
- RGLS annual net income is now -295.12% below its all-time high of -$7.60 million, reached on December 31, 2011.
Performance
RGLS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$14.06 M
-$3.03 M-27.42%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly net profit is -$14.06 million, with the most recent change of -$3.03 million (-27.42%) on September 30, 2024.
- Over the past year, RGLS quarterly net income has dropped by -$3.03 million (-27.42%).
- RGLS quarterly net income is now -1245.65% below its all-time high of -$1.04 million, reached on September 30, 2011.
Performance
RGLS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$41.63 M
-$6.24 M-17.63%
September 30, 2024
Summary
- As of February 8, 2025, RGLS TTM net profit is -$41.63 million, with the most recent change of -$6.24 million (-17.63%) on September 30, 2024.
- Over the past year, RGLS TTM net income has dropped by -$6.24 million (-17.63%).
- RGLS TTM net income is now -3883.54% below its all-time high of -$1.04 million, reached on September 30, 2011.
Performance
RGLS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RGLS Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.0% | -27.4% | -17.6% |
| 3 y3 years | -91.0% | -93.7% | -40.0% |
| 5 y5 years | +38.3% | -159.3% | -163.4% |
RGLS Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.0% | at low | -109.3% | at low | -49.7% | at low |
| 5 y | 5-year | -91.0% | at low | -963.7% | at low | -179.5% | at low |
| alltime | all time | -295.1% | +63.3% | -1245.7% | +36.6% | -3883.5% | +49.1% |
Regulus Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.06 M(+27.4%) | -$41.63 M(+17.6%) |
| Jun 2024 | - | -$11.04 M(+30.3%) | -$35.39 M(+12.8%) |
| Mar 2024 | - | -$8.47 M(+5.1%) | -$31.37 M(+4.4%) |
| Dec 2023 | -$30.04 M(+6.1%) | -$8.06 M(+3.0%) | -$30.04 M(+4.4%) |
| Sep 2023 | - | -$7.82 M(+11.6%) | -$28.77 M(+1.0%) |
| Jun 2023 | - | -$7.01 M(-1.8%) | -$28.50 M(-0.9%) |
| Mar 2023 | - | -$7.14 M(+5.1%) | -$28.74 M(+1.5%) |
| Dec 2022 | -$28.32 M(+1.9%) | -$6.79 M(-10.0%) | -$28.32 M(-1.2%) |
| Sep 2022 | - | -$7.55 M(+4.0%) | -$28.66 M(-3.6%) |
| Jun 2022 | - | -$7.26 M(+8.0%) | -$29.74 M(+4.3%) |
| Mar 2022 | - | -$6.72 M(-5.8%) | -$28.51 M(+2.5%) |
| Dec 2021 | -$27.81 M(+76.8%) | -$7.13 M(-17.3%) | -$27.81 M(+26.4%) |
| Sep 2021 | - | -$8.63 M(+43.0%) | -$22.00 M(+47.7%) |
| Jun 2021 | - | -$6.03 M(+0.3%) | -$14.89 M(-5.8%) |
| Mar 2021 | - | -$6.01 M(+354.8%) | -$15.81 M(+0.5%) |
| Dec 2020 | -$15.73 M(-15.4%) | -$1.32 M(-13.3%) | -$15.73 M(-18.5%) |
| Sep 2020 | - | -$1.52 M(-78.1%) | -$19.30 M(-16.8%) |
| Jun 2020 | - | -$6.95 M(+17.0%) | -$23.20 M(+9.1%) |
| Mar 2020 | - | -$5.94 M(+21.3%) | -$21.27 M(+14.4%) |
| Dec 2019 | -$18.59 M(-61.8%) | -$4.89 M(-9.8%) | -$18.59 M(-16.5%) |
| Sep 2019 | - | -$5.42 M(+8.1%) | -$22.26 M(-17.9%) |
| Jun 2019 | - | -$5.02 M(+53.9%) | -$27.11 M(-24.6%) |
| Mar 2019 | - | -$3.26 M(-61.9%) | -$35.94 M(-26.2%) |
| Dec 2018 | -$48.71 M(-32.3%) | -$8.56 M(-16.6%) | -$48.71 M(-10.8%) |
| Sep 2018 | - | -$10.27 M(-25.8%) | -$54.59 M(-9.2%) |
| Jun 2018 | - | -$13.85 M(-13.6%) | -$60.15 M(-11.4%) |
| Mar 2018 | - | -$16.02 M(+10.9%) | -$67.91 M(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$71.91 M(-12.1%) | -$14.45 M(-8.7%) | -$71.91 M(-7.2%) |
| Sep 2017 | - | -$15.83 M(-26.7%) | -$77.48 M(-4.5%) |
| Jun 2017 | - | -$21.61 M(+7.9%) | -$81.17 M(+0.6%) |
| Mar 2017 | - | -$20.02 M(+0.0%) | -$80.65 M(-1.4%) |
| Dec 2016 | -$81.84 M(+46.8%) | -$20.02 M(+2.6%) | -$81.84 M(+18.5%) |
| Sep 2016 | - | -$19.52 M(-7.4%) | -$69.04 M(+10.4%) |
| Jun 2016 | - | -$21.09 M(-0.6%) | -$62.52 M(+0.1%) |
| Mar 2016 | - | -$21.21 M(+193.5%) | -$62.47 M(+12.1%) |
| Dec 2015 | -$55.75 M(-1.6%) | -$7.23 M(-44.4%) | -$55.75 M(-21.1%) |
| Sep 2015 | - | -$13.00 M(-38.2%) | -$70.69 M(+4.7%) |
| Jun 2015 | - | -$21.04 M(+45.2%) | -$67.49 M(+15.5%) |
| Mar 2015 | - | -$14.49 M(-34.6%) | -$58.43 M(+3.1%) |
| Dec 2014 | -$56.68 M(+203.6%) | -$22.17 M(+126.3%) | -$56.68 M(+55.5%) |
| Sep 2014 | - | -$9.80 M(-18.2%) | -$36.44 M(+26.5%) |
| Jun 2014 | - | -$11.97 M(-6.0%) | -$28.80 M(+19.1%) |
| Mar 2014 | - | -$12.74 M(+561.2%) | -$24.18 M(+29.5%) |
| Dec 2013 | -$18.67 M(+7.2%) | -$1.93 M(-11.0%) | -$18.67 M(-21.0%) |
| Sep 2013 | - | -$2.16 M(-70.5%) | -$23.62 M(-13.0%) |
| Jun 2013 | - | -$7.35 M(+1.6%) | -$27.14 M(+21.2%) |
| Mar 2013 | - | -$7.23 M(+5.1%) | -$22.39 M(+28.6%) |
| Dec 2012 | -$17.41 M(+129.0%) | -$6.88 M(+20.9%) | -$17.41 M(+38.7%) |
| Sep 2012 | - | -$5.68 M(+118.7%) | -$12.55 M(+58.7%) |
| Jun 2012 | - | -$2.60 M(+15.7%) | -$7.91 M(+49.0%) |
| Mar 2012 | - | -$2.25 M(+11.5%) | -$5.31 M(+73.4%) |
| Dec 2011 | -$7.60 M(-51.1%) | -$2.02 M(+92.8%) | -$3.06 M(+192.8%) |
| Sep 2011 | - | -$1.04 M | -$1.04 M |
| Dec 2010 | -$15.56 M | - | - |
FAQ
- What is Regulus Therapeutics annual net profit?
- What is the all time high annual net income for Regulus Therapeutics?
- What is Regulus Therapeutics annual net income year-on-year change?
- What is Regulus Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly net income year-on-year change?
- What is Regulus Therapeutics TTM net profit?
- What is the all time high TTM net income for Regulus Therapeutics?
- What is Regulus Therapeutics TTM net income year-on-year change?
What is Regulus Therapeutics annual net profit?
The current annual net income of RGLS is -$30.04 M
What is the all time high annual net income for Regulus Therapeutics?
Regulus Therapeutics all-time high annual net profit is -$7.60 M
What is Regulus Therapeutics annual net income year-on-year change?
Over the past year, RGLS annual net profit has changed by -$1.71 M (-6.05%)
What is Regulus Therapeutics quarterly net profit?
The current quarterly net income of RGLS is -$14.06 M
What is the all time high quarterly net income for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly net profit is -$1.04 M
What is Regulus Therapeutics quarterly net income year-on-year change?
Over the past year, RGLS quarterly net profit has changed by -$3.03 M (-27.42%)
What is Regulus Therapeutics TTM net profit?
The current TTM net income of RGLS is -$41.63 M
What is the all time high TTM net income for Regulus Therapeutics?
Regulus Therapeutics all-time high TTM net profit is -$1.04 M
What is Regulus Therapeutics TTM net income year-on-year change?
Over the past year, RGLS TTM net profit has changed by -$6.24 M (-17.63%)